75 related articles for article (PubMed ID: 14517716)
1. The contribution of familial resemblance to variation in circulatory levels of tissue inhibitors of metalloproteinases and transforming growth factor-beta1.
Pantsulaia I; Trofimov S; Kalichman L; Kobyliansky E; Livshits G
Calcif Tissue Int; 2004 Jan; 74(1):47-54. PubMed ID: 14517716
[TBL] [Abstract][Full Text] [Related]
2. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
[TBL] [Abstract][Full Text] [Related]
3. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase, tissue inhibitor of metalloproteinase and transforming growth factor-beta 1 in frozen shoulder, and their changes as response to intensive stretching and supervised neglect exercise.
Lubis AM; Lubis VK
J Orthop Sci; 2013 Jul; 18(4):519-27. PubMed ID: 23604641
[TBL] [Abstract][Full Text] [Related]
5. Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B.
Flisiak R; Al-Kadasi H; Jaroszewicz J; Prokopowicz D; Flisiak I
World J Gastroenterol; 2004 Sep; 10(18):2661-5. PubMed ID: 15309715
[TBL] [Abstract][Full Text] [Related]
6. Heritability of circulating growth factors involved in the angiogenesis in healthy human population.
Pantsulaia I; Trofimov S; Kobyliansky E; Livshits G
Cytokine; 2004 Sep; 27(6):152-8. PubMed ID: 15304244
[TBL] [Abstract][Full Text] [Related]
7. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
[TBL] [Abstract][Full Text] [Related]
8. Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta.
Kuźnik-Trocha K; Winsz-Szczotka K; Komosińska-Vassev K; Jura-Półtorak A; Kotulska-Kucharz A; Kucharz EJ; Kotyla P; Olczyk K
Biomed Res Int; 2020; 2020():6416514. PubMed ID: 32382564
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucoma/syndrome.
Djordjević-Jocić J; Zlatanović G; Veselinović D; Jovanović P; Djordjević V; Zvezdanović L; Stanković-Babić G; Vujanović M; Cekić S; Zenkel M; Schlotzer-Schrehardt U
Vojnosanit Pregl; 2012 Mar; 69(3):231-6. PubMed ID: 22624408
[TBL] [Abstract][Full Text] [Related]
10. TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles.
Offenberg H; Brünner N; Mansilla F; Orntoft Torben F; Birkenkamp-Demtroder K
Mol Oncol; 2008 Oct; 2(3):233-40. PubMed ID: 19383344
[TBL] [Abstract][Full Text] [Related]
11. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1.
Lee YM; Kim SS; Kim HA; Suh YJ; Lee SK; Nahm DH; Park HS
J Korean Med Sci; 2003 Feb; 18(1):97-102. PubMed ID: 12589095
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction.
Kelly D; Squire IB; Khan SQ; Dhillon O; Narayan H; Ng KH; Quinn P; Davies JE; Ng LL
Am J Cardiol; 2010 Aug; 106(4):477-82. PubMed ID: 20691304
[TBL] [Abstract][Full Text] [Related]
15. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Lorenzl S; Buerger K; Hampel H; Beal MF
Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
[TBL] [Abstract][Full Text] [Related]
16. [Effect of transforming growth factor β1 on the expression of matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and nuclear factor kappa B signalling pathway in the human amniotic cells WISH].
Fan MS; Jiang ZY; Zou YF; Qu L; Zhou X; Sun LZ
Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):29-33. PubMed ID: 23531248
[TBL] [Abstract][Full Text] [Related]
17. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.
Cotrim P; de Andrade CR; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD
J Periodontol; 2002 Nov; 73(11):1313-22. PubMed ID: 12479636
[TBL] [Abstract][Full Text] [Related]
19. [Transforming growth factor beta, metalloproteinase 2 and its tissue inhibitor 2 in the serum from patients with early and late boreliosis].
Pancewicz SA; Izycka A; Klibingat M; Zajkowska JM; Swierzbińska-Pijanowska R; Kondrusik M; Grygorczuk SS; Izycki T; Hermanowska-Szpakowicz T
Pol Merkur Lekarski; 2008 Dec; 25(150):495-9. PubMed ID: 19205380
[TBL] [Abstract][Full Text] [Related]
20. Age- and gender-dependent changes in connective tissue remodeling: physiological differences in circulating MMP-3, MMP-10, TIMP-1 and TIMP-2 level.
Komosinska-Vassev K; Olczyk P; Winsz-Szczotka K; Kuznik-Trocha K; Klimek K; Olczyk K
Gerontology; 2011; 57(1):44-52. PubMed ID: 20215736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
